Cosmo Pharmaceuticals S.p.A Stock Deutsche Boerse AG
Stocks
IT0004167463
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Deutsche Boerse AG
|
||
| - EUR | - |
|
| 08-28 | Beyond the Scale: Men turn to cosmetic clinics to complete weight-loss transformation | RE |
| 08-14 | Cosmo Pharmaceuticals to Adopt New Ticker on SIX Swiss Exchange | MT |
| Market Cap | 958M 1.07B 894M 812M 1.53B 104B 1.54B 10.74B 4.2B 52.76B 4.03B 3.94B 170B | P/E 2026 * |
829x | P/E 2027 * | 19.3x |
|---|---|---|---|---|---|
| Enterprise Value | 930M 1.04B 867M 788M 1.48B 101B 1.49B 10.42B 4.07B 51.19B 3.91B 3.82B 165B | EV / Sales 2026 * |
8.75x | EV / Sales 2027 * | 5.28x |
| Free-Float |
40.52% | Yield 2026 * |
3.81% | Yield 2027 * | 4.05% |
Last Transcript: Cosmo Pharmaceuticals S.p.A
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | 2024-05-23 | |
| Director of Finance/CFO | - | 2024-11-10 | |
Paolo Lanzarotti
CTO | Chief Tech/Sci/R&D Officer | 53 | 2008-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Mauro Ajani
CHM | Chairman | 71 | 2013-12-31 |
| Director/Board Member | 71 | 2012-03-31 | |
Niall Donnelly
BRD | Director/Board Member | 54 | 2024-05-23 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.70% | +2.73% | +40.91% | +107.91% | 1,032B | |
| +1.44% | -2.38% | +36.83% | +63.02% | 614B | |
| +1.75% | +3.73% | +16.55% | +81.99% | 471B | |
| +0.60% | -1.73% | +62.98% | +36.64% | 350B | |
| +2.92% | +3.06% | +24.83% | +45.10% | 337B | |
| +2.42% | -0.74% | +13.44% | +35.80% | 268B | |
| +1.86% | -0.81% | -4.69% | +12.20% | 246B | |
| +2.60% | -2.00% | +39.77% | +52.12% | 218B | |
| +1.82% | -1.48% | +25.75% | +95.64% | 179B | |
| Average | +1.84% | -3.39% | +28.48% | +58.94% | 412.76B | |
| Weighted average by Cap. | +2.02% | -3.18% | +31.96% | +69.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 106M 119M 99.17M 90.08M 170M 11.51B 171M 1.19B 466M 5.85B 447M 437M 18.81B | 176M 197M 164M 149M 281M 19.06B 283M 1.97B 771M 9.69B 740M 724M 31.15B |
| Net income | 1.27M 1.43M 1.19M 1.08M 2.03M 138M 2.05M 14.29M 5.58M 70.18M 5.36M 5.24M 226M | 49.6M 55.51M 46.28M 42.03M 79.16M 5.37B 79.76M 556M 217M 2.73B 208M 204M 8.78B |
| Net Debt | -28.5M -31.9M -26.59M -24.15M -45.48M -3.09B -45.82M -320M -125M -1.57B -120M -117M -5.04B | -28.81M -32.24M -26.87M -24.41M -45.97M -3.12B -46.32M -323M -126M -1.59B -121M -118M -5.1B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
